Clinical Trial Update: A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dostarlimab versus placebo after chemoradiation in locally advanced unresected head and neck squamous cell carcinoma is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Dostarlimab (dostarlimab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Head and Neck | Phase 3 | Status: RECRUITING